Qorvo (QRVO) director Alan S. Lowe awarded 2,327 shares of common stock

Rhea-AI Filing Summary

LOWE ALAN S reported acquisition or exercise transactions in this Form 4 filing.

Qorvo, Inc. director Alan S. Lowe reported a grant of 2,327 shares of common stock on August 12, 2026, recorded at $0.00 per share as a grant or award rather than a market purchase. Following this award, his directly held common stock position totals 7,233 shares. The transaction was not reported under a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Buyer: 2,327 shares

Net Buy 1 txn

Insider LOWE ALAN S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,327	$0.00	$0.00

Holdings After Transaction: Common Stock — 7,233 shares (Direct)

Key Figures

Shares granted: 2,327 shares Price per share: $0.00 per share Shares owned after: 7,233 shares +2 more

5 metrics

Shares granted 2,327 shares Non-derivative common stock award on August 12, 2026

Price per share $0.00 per share Recorded value for the stock grant transaction

Shares owned after 7,233 shares Direct common stock holdings after the reported grant

Transaction code A Grant, award, or other acquisition of common stock

Transaction date August 12, 2026 Date of the reported grant of common stock

Key Terms

Grant, award, or other acquisition, Non-derivative, Rule 10b5-1

3 terms

Grant, award, or other acquisition regulatory

"Transaction code A indicates a Grant, award, or other acquisition"

Non-derivative financial

"The reported transaction involves non-derivative Common Stock"

Rule 10b5-1 regulatory

"The transaction was not reported under a Rule 10b5-1 trading plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did QRVO director Alan S. Lowe report?

Alan S. Lowe reported a grant of 2,327 shares of Qorvo common stock on August 12, 2026. The Form 4 classifies this as a grant, award, or other acquisition of non-derivative common stock.

How many QRVO shares does Alan S. Lowe hold after this Form 4 transaction?

After the reported grant, Alan S. Lowe directly holds 7,233 shares of Qorvo common stock. This figure reflects his position following the August 12, 2026 award of 2,327 shares reported in the filing.

Was the QRVO Form 4 transaction for Alan S. Lowe a market purchase or a grant?

The transaction was a grant or award, not a market purchase. It is coded as “A” on the Form 4, with $0.00 per-share price, indicating an award of common stock rather than an open-market buy.

Did Alan S. Lowe’s QRVO stock grant occur under a Rule 10b5-1 trading plan?

No. The Form 4’s Rule 10b5-1 checkbox is not marked as being pursuant to a trading plan. This indicates the reported stock grant was not executed under an affirmed Rule 10b5-1 arrangement.

What security is involved in Alan S. Lowe’s latest QRVO Form 4 filing?

The filing reports a transaction in Qorvo, Inc. common stock. It shows a non-derivative award of 2,327 shares of common stock to director Alan S. Lowe, increasing his directly held position to 7,233 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 05:04 PM Accepted by SEC EDGAR 08/13/2026 - 05:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LOWE ALAN S

(Last) (First) (Middle)

C/O QORVO, INC.

7628 THORNDIKE ROAD

(Street)

GREENSBORO NORTH CAROLINA 27409

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Qorvo, Inc. [ QRVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		A		2,327	A	$0	7,233	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jason T. Gray, by Power of Attorney	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)